RhyGaze

Developing gene therapies for retinal diseases causing blindness.

Sector

Life Sciences

Category

Therapeutics

Locations

Basel, Switzerland
Philadelphia, PA

Initial Investment

2024
Developing gene therapies for retinal diseases causing blindness.

RhyGaze is a cutting-edge biotechnology company based in Basel, Switzerland, and Philadelphia, Pa., USA, focused on developing gene therapies for retinal diseases causing blindness. Founded on pioneering research from the Institute of Molecular and Clinical Ophthalmology Basel (IOB), RhyGaze aims to restore vision and transform the lives of patients worldwide. IOB scientists Drs. Botond Roska, Bence György and Charles Gubser are the scientific founders of RhyGaze.